At APOCARE we do not see ourselves merely as suppliers of generics. Since 2003 we have placed great value on independent research and development of oncological procedures. Pioneering research work on the development of photodynamic therapy (PDT) was carried out in close cooperation with German and international research institutes. A phase IIb study in NSCLC was completed in 2018.